Patents by Inventor Nikolai Sopko

Nikolai Sopko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11583571
    Abstract: Stromal Derived Factor-1 (SDF-1) is a small, naturally occurring, potent chemokine with inherent angiogenic, neurogenic, anti-apoptotic protein, which is also a potent stem cell chemoattractant, cardiovascular disease, and other metabolic disturbances. The present invention provides methods for treating erectile dysfunction in a male subject comprising administering to the major pelvic ganglion supplying the cavernous nerves subject compositions comprising SDF-1. SDF-1 promotes stem cell activation, to the major pelvic ganglion supplying the cavernous nerves, helps cell preservation, and prevents adverse penile remodeling. It can be administered as a protein or by gene therapy including but not limited to plasmid DNA, viral transduction, or nanoparticle delivery directly to the penis or to the neurovascular bundle or other pelvic nerve structures during the time of surgery, or before injury, or to treat existing erectile dysfunction.
    Type: Grant
    Filed: May 11, 2018
    Date of Patent: February 21, 2023
    Assignees: The Johns Hopkins University, Summa Health System
    Inventors: Nikolai Sopko, Trinity Bivalacqua, Marc Penn
  • Publication number: 20200188483
    Abstract: Stromal Derived Factor-1 (SDF-1) is a small, naturally occurring, potent chemokine with inherent angiogenic, neurogenic, anti-apoptotic protein, which is also a potent stem cell chemoattractant, cardiovascular disease, and other metabolic disturbances. The present invention provides methods for treating erectile dysfunction in a male subject comprising administering to the major pelvic ganglion supplying the cavernous nerves subject compositions comprising SDF-1. SDF-1 promotes stem cell activation, to the major pelvic ganglion supplying the cavernous nerves, helps cell preservation, and prevents adverse penile remodeling. It can be administered as a protein or by gene therapy including but not limited to plasmid DNA, viral transduction, or nanoparticle delivery directly to the penis or to the neurovascular bundle or other pelvic nerve structures during the time of surgery, or before injury, or to treat existing erectile dysfunction.
    Type: Application
    Filed: May 11, 2018
    Publication date: June 18, 2020
    Inventors: Nikolai Sopko, Trinity Bivalacqua, Marc Penn
  • Publication number: 20190365952
    Abstract: The present invention provides a tissue scaffold mold apparatus and methods for use of the mold apparatus to simply, rapidly and easily form molded tissue scaffolds from fibrous proteins such as collagen, and with other matrix components having complex 3-dimensional designs that can be seeded with stem cells for creating biologically and mechanically functional tissues/grafts. The inventive methods and apparatus allows for tissue engineering of hollow or concave and tubular organs and tissues, and will have immediate impact in a wide range of biomedical areas from tissue engineering, regeneration and reconstructive surgery.
    Type: Application
    Filed: January 19, 2018
    Publication date: December 5, 2019
    Inventors: Anirudha Singh, Trinity Bivalacqua, Nikolai Sopko, David Lee
  • Publication number: 20190328933
    Abstract: Disclosed herein is a composition comprising stimulated biological material derived from an interface compartment, wherein the composition is capable of augmenting the generation or healing of a native tissue when administered to a subject in need thereof.
    Type: Application
    Filed: July 10, 2019
    Publication date: October 31, 2019
    Inventors: Denver Lough, Nikolai Sopko, Pratima Labroo, Nicholas William Baetz, Jennifer Jensen Irvin, Georgia Crystal Yalanis, Matthew Petney
  • Publication number: 20190231927
    Abstract: Disclosed herein is a composition comprising stimulated biological material derived from an interface compartment, wherein the composition is capable of augmenting the generation or healing of a native tissue when administered to a subject in need thereof.
    Type: Application
    Filed: January 28, 2019
    Publication date: August 1, 2019
    Inventors: Denver Lough, Nikolai Sopko, Pratima Labroo, Nicholas William Baetz, Jennifer Jensen Irvin, Georgia Crystal Yalanis, Matthew Petney
  • Publication number: 20190231932
    Abstract: Disclosed herein is a composition comprising a stimulated heterogeneous mammalian tissue interface cell aggregate that is capable of producing functional polarized tissue when administered to a subject in need thereof.
    Type: Application
    Filed: January 28, 2019
    Publication date: August 1, 2019
    Inventors: Denver Lough, Nikolai Sopko, Pratima Labroo, Nicholas Baetz